Viatris Agrees to Settle EpiPen Antitrust Litigation for $264 Million. Compensation for Damages (Law), Epinephrine (Drug), Suits and Litigation (Civil), Pfizer Inc, Medical Devices, Mylan Inc, Viatris Inc